搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Medical Xpress
24 天
How liver tissue from the International Space Station may transform tissue engineering
Led by Tammy T. Chang, MD, Ph.D., FACS, a professor of surgery at the University of California, San Francisco, the Chang Laboratory for Liver Tissue Engineering is pioneering the self-assembly of ...
HealthDay on MSN
10 天
Scientists Successfully Reverse Liver Fibrosis in Mice
Cirrhosis, hepatitis infection and other causes can trigger liver fibrosis -- a potentially lethal stiffening of tissue ...
tyla
12 天
Doctor issues warning over five signs that could mean you have serious liver damage
A doctor has explained five signs that could mean you have serious liver damage. Now, your liver is responsible for a whole ...
Armed robbery in Revesby
3 天
High-Mobility Group Box-1's New Role in Liver Disease
Liver diseases, both acute and chronic, continue to pose significant clinical challenges due to high morbidity and mortality ...
EurekAlert!
4 天
Metabolic dysregulation and metabolite imbalances in acute-on-chronic liver failure: Impact ...
Liver failure encompasses a range of severe clinical syndromes resulting from the deterioration of liver function, triggered ...
News Medical on MSN
2 天
HMGB1 as a key mediator in liver disease pathogenesis
Liver diseases, both acute and chronic, continue to pose significant clinical challenges due to high morbidity and mortality ...
Managed Healthcare Executive
7 天
Semaglutide Improves Liver Fibrosis in New Trial Analysis
In the ESSENCE trial, semaglutide improved liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis ...
10 天
Popular Weight Loss Drug Wegovy Shows Encouraging Results in Liver Fibrosis Trial
On Friday, Novo Nordisk A/S (NYSE:NVO) released headline results from part 1 of the ongoing ESSENCE Phase 3 trial, a 240-week ...
The Pharma Letter
10 天
Semaglutide shows superior improvement in both liver fibrosis and MASH resolution
Denmark’s Novo Nordisk (NOV: N) bucked a down trending market today, rising 1% on promising research results. The diabetes ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈